BridgeBio Pharma Inc (BBIO) support and resistance · rev $221.9M
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
This page maps BridgeBio Pharma Inc (BBIO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
BBIO currently screens at market cap $13.24B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BBIO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BBIO quote page for the session range and the stock page for the full model.
Not investment advice.